After 1 h of lithium-pilocarpine status epilepticus (SE), immunocytochemical labeling of NMDA receptor NR1 subunits reveals relocation of subunits from the interior to the cell surface of dentate gyrus granule cells and CA3 pyramidal cells. Simultaneously, an increase in NMDA-miniature excitatory postsynaptic currents (mEPSC) as well as an increase in NMDA receptor-mediated tonic currents is observed in hippocampal slices after SE. Mean-variance analysis of NMDA-mEPSCs estimates that the number of functional postsynaptic NMDA receptors per synapse increases 38% during SE, and antagonism by ifenprodil suggests that an increase in the surface representation of NR2B-containing NMDA receptors is responsible for the augmentation of both the phasic and tonic excitatory currents with SE. These results provide a potential mechanism for an enhancement of glutamatergic excitation that maintains SE and may contribute to excitotoxic injury during SE. Therapies that directly antagonize NMDA receptors may be a useful therapeutic strategy during refractory SE.
Introduction
Despite the emergence of several new anticonvulsants, status epilepticus (SE) is a major health concern with significant morbidity and a high mortality (DeLorenzo et al., 1996) . As seizures persist, SE becomes self-sustaining and increasingly difficult to treat (Alldredge et al., 2001; Mazarati et al., 1998a; Silbergleit et al., 2012; Treiman et al., 1998) , even after removal of the initial convulsant trigger (Mazarati et al., 1998b; Morrisett et al., 1987; Suchomelova et al., 2006) . Previously we found that trafficking of GABA A receptors, with relocation of subunits from synapses to the cell interior, contributes to a loss of postsynaptic inhibition in hippocampal dentate gyrus granule cells and may explain the initiation of self-sustaining SE and the development of benzodiazepine pharmacoresistance (Naylor et al., 2005) . While most GABAergic enhancing agents quickly lose effectiveness during the course of SE (Goodkin and Kapur, 2003; Jones et al., 2002; Kapur and Macdonald, 1997; Mazarati et al., 1998a; Rice and DeLorenzo, 1998, 1999; Treiman et al., 1998) , NMDA antagonists retain effectiveness in the late stages of SE (Mazarati and Wasterlain, 1999; McDonald et al., 1990a; Mewasingh et al., 2003; Yen et al., 2004) suggesting that NMDA receptors remain available for pharmacological intervention throughout SE.
Although NMDA receptor trafficking is important in many processes including development/experience (Quinlan et al., 1999a (Quinlan et al., , 1999b van Zundert et al., 2004) , synaptic plasticity/LTP (Carroll and Zukin, 2002; Grosshans et al., 2002; Watt et al., 2004) , degenerative disorders (Chen et al., 1999c; Lau and Zukin, 2007; Snyder et al., 2005) , and excitotoxicity/cell death (DeRidder et al., 2006; Gee et al., 2006; Guerguerian et al., 2002; Johnston et al., 2002; Lekishvili et al., 2006; Manzerra et al., 2001) , the role of NMDA receptor trafficking in SE has not been investigated in detail. To explore the importance of NMDA receptors in maintaining SE, we studied the trafficking of NMDA receptor subunits and found a relocation of NMDA receptor subunits towards the cell surface with an associated increase in excitation involving synaptic as well as tonic currents. This augmented excitation, coupled with a loss of synaptic inhibition (Naylor et al., 2005) , provides an important mechanism for seizure maintenance during SE and may contribute to SE-related excitotoxicity (Fujikawa, 1995; Hardingham et al., 2002; Rice and DeLorenzo, 1998) . It also may contribute to synaptic plasticity during the epileptogenic process (Delorenzo et al., 2005; Mazarati et al., 2002a) -since progression to a chronic epileptic state frequently follows SE (Lothman et al., 1990; Mazarati et al., 1998b; Rice and DeLorenzo, 1998) . Neurobiology of Disease 54 (2013) [225] [226] [227] [228] [229] [230] [231] [232] [233] [234] [235] [236] [237] [238] 
